Search results for "elder"

showing 10 items of 919 documents

Physiotherapists' accounts of their clients in geriatric inpatient rehabilitation.

2008

This article aims to describe how physiotherapists working with frail older people talk about their clients. Semi-structured qualitative interviews with physiotherapists (n = 11) were audio recorded, transcribed and analysed using discourse analysis. Two accounts were identified: (i) older adults as recipients of a treatment intervention at the rehabilitation centre, with the dimensions 'a focus on physical impairments' and 'a focus on social needs' and (ii) older adults as partners in an exercise intervention to support their everyday living at home. Older adults' everyday living context was not considered in the approach where, in an isolated and objectified manner, the physiotherapists f…

AdultMaleHealth Services for the AgedDiscourse analysismedicine.medical_treatmentFrail ElderlyMEDLINEContext (language use)Health PromotionInterviews as TopicNursingSocial needsmedicineHumansFinlandPhysical Therapy ModalitiesAgedAged 80 and overInpatientsRehabilitationbusiness.industryQualitative interviewsPublic Health Environmental and Occupational HealthProfessional-Patient RelationsMiddle AgedHealth promotionFemalebusinessInpatient rehabilitationScandinavian journal of caring sciences
researchProduct

Age of onset of episodic and chronic cluster headache – a review of a large case series from a single headache centre

2016

Background In the largest case series of cluster headache (CH) published in the literature, age of onset varies between 29.6 and 31.6 years. Differences in onset age based on gender and subtype diagnosis are reported, while there are only few data on patients with childhood and elderly onset. We therefore deemed it useful to review our own large case series of CH patients. Methods The age of onset of cluster headache was investigated in a consecutive case series of 808 patients (585 men and 223 women), including 686 (503 men and 183 women) with episodic cluster headache (ECH), 103 (66 men and 37 women) with chronic cluster headache (CCH), and 19 with an indeterminate form of CH (16 men and …

AdultMalePediatricsmedicine.medical_specialtyNeurologyAdolescentClinical NeurologyCluster Headache03 medical and health sciences0302 clinical medicineAge DistributionPredictive Value of TestsEpidemiologyMedicineHumansIn patient030212 general & internal medicineAge of OnsetSex DistributionChildAgedSeries (stratigraphy)business.industryCluster headacheInfantGeneral MedicineConsecutive case seriesMiddle Agedmedicine.diseaseAnesthesiology and Pain MedicineItalyChild PreschoolChronic DiseaseDisease ProgressionElderly onsetFemaleNeurology (clinical)Age of onsetbusiness030217 neurology & neurosurgeryBiomarkersResearch ArticleThe Journal of Headache and Pain
researchProduct

Pattern of symptoms and symptomatic treatment in adults and the aged population: a retrospective analysis of advanced cancer patients followed at hom…

2016

Context Data regarding symptom burden and symptomatic drugs in palliative population in different classes of age are lacking. Objective The aim of this retrospective study was to assess the symptom burden, and the profile of symptomatic drugs in the last four weeks of life in adults and older cancer patients followed at home. Methods Charts of 412 patients were retrospectively analyzed by using a backward analysis. Patients were divided into three groups: adults (<65 years, A), old (65-74 years, O1), very old (75-84 years, O2), and the oldest (≥85 years, O3). Results At -4W Karnofsky status was significantly lower for older people (p = 0.03). No significant effect of age on the vector of sy…

AdultMalePediatricsmedicine.medical_specialtyPalliative careNauseaPopulationSymptomatic treatmentPainHome care03 medical and health sciences0302 clinical medicineElderlyAdvanced cancerNeoplasmsRetrospective analysisOld patientsMedicineHumans030212 general & internal medicineAdvanced cancer; Drugs; Elderly; Home care; Old patients; Palliative care; Symptoms; Medicine (all)Karnofsky Performance StatuseducationAgedRetrospective StudiesAged 80 and overeducation.field_of_studybusiness.industryMedicine (all)Anti-Inflammatory Agents Non-SteroidalAge FactorsCancerDrugsRetrospective cohort studyNauseaGeneral MedicineMiddle Agedmedicine.diseaseAdvanced cancerHome Care ServicesAnalgesics Opioid030220 oncology & carcinogenesisSymptomsPalliative careAntiemeticsFemalemedicine.symptombusinessCurrent medical research and opinion
researchProduct

Comparing asthma treatment in elderly versus younger patients

2011

SummaryA randomised 6-month study compared two maintenance doses of budesonide/formoterol (Symbicort® Turbuhaler®)hhNeither the Symbicort SMART posology nor the dry powder formulation, Turbuhaler, is currently approved in the US. maintenance and reliever therapy (Symbicort SMART®), 160/4.5 μg 1 × 2 and 2 × 2, in 8053 asthmatics with symptoms despite treatment with inhaled corticosteroids ± inhaled long-acting β2-agonists. This analysis compared response to the two treatments in elderly patients, ≥65 years, with that in younger patients. Elderly patients with early- or late-onset asthma were also compared.Elderly patients had lower post-bronchodilator FEV1 percentage predicted normal at base…

AdultMalePulmonary and Respiratory MedicineBudesonideSymbicort SMARTmedicine.medical_specialtylaw.inventionExacerbationsElderlyRandomized controlled triallawFormoterol FumarateSurveys and QuestionnairesInternal medicineAdministration InhalationmedicineHumansBudesonideBudesonide/formoterolAgedAsthmaACQDose-Response Relationship Drugbusiness.industryHazard ratiomedicine.diseaseConfidence intervalAsthmaBronchodilator AgentsSurgeryTreatment OutcomeBudesonide/formoterolEthanolaminesAsthma Control QuestionnaireDisease ProgressionQuality of LifeDrug Therapy CombinationFemaleFormoterolbusinessmedicine.drugRespiratory Medicine
researchProduct

Consensus meeting: monosodium glutamate – an update

2006

Update of the Hohenheim consensus on monosodium glutamate from 1997: Summary and evaluation of recent knowledge with respect to physiology and safety of monosodium glutamate.Experts from a range of relevant disciplines received and considered a series of questions related to aspects of the topic.University of Hohenheim, Stuttgart, Germany.The experts met and discussed the questions and arrived at a consensus.Total intake of glutamate from food in European countries is generally stable and ranged from 5 to 12 g/day (free: ca. 1 g, protein-bound: ca. 10 g, added as flavor: ca. 0.4 g). L-Glutamate (GLU) from all sources is mainly used as energy fuel in enterocytes. A maximum intake of 6.000 [c…

AdultMalemedicine.medical_specialtyAdolescentMonosodium glutamatePopulationMedicine (miscellaneous)Physiologychemistry.chemical_compoundBolus (medicine)Elderly personsPregnancyInternal medicineSodium GlutamatemedicineHumansPalatabilityChildeducationAgedAged 80 and overeducation.field_of_studyNutrition and DieteticsDose-Response Relationship DrugAppetite Regulationbusiness.industryInfant NewbornGlutamate receptorInfantMiddle AgedFood safetyFlavoring AgentsHuman nutritionEndocrinologychemistryBlood-Brain BarrierConsumer Product SafetyChild PreschoolPrenatal Exposure Delayed EffectsFemaleFood AdditivesbusinessEuropean Journal of Clinical Nutrition
researchProduct

Standing up from a chair as a dynamic equilibrium task: a comparison between young and elderly subjects.

2000

The purpose of this study was to analyze and compare the features of center of mass (CoM) control along anterior/posterior axis in young and elderly subjects during sit-to-stand (STS). From a sitting position, seven healthy young subjects and seven healthy elderly subjects were asked to stand up from a chair under different experimental conditions (visual conditions: normal and blindfolded; speed: normal and as fast as possible). Analysis of results was based upon the concept of a “dynamic equilibrium area” (DEA), which in turn identified the dynamic limits of balance. The results showed that both the maximal CoM velocity in the horizontal axis and the CoM velocity at the instant of seat-of…

AdultMalemedicine.medical_specialtyAgingOptics and PhotonicsTime FactorsBody heightMovementeducationPostureSittingBase of supportDisplacement (vector)Motion (physics)Physical medicine and rehabilitationTask Performance and AnalysisMedicineHumansPostural BalanceVision OcularBalance (ability)AgedHorizontal axisAged 80 and overLegbusiness.industryBody WeightHealthy elderlyhumanitiesBody HeightLinear ModelsFemaleStress MechanicalGeriatrics and GerontologyElectronicsbusinesshuman activitiesAlgorithmsThe journals of gerontology. Series A, Biological sciences and medical sciences
researchProduct

Comparison of repositioning maneuvers for benign paroxysmal positional vertigo of posterior semicircular canal: advantages of hybrid maneuver.

2012

Objective: The prevalence of benign paroxysmal positional vertigo (BPPV) is becoming more frequent in elderly population. The presence of comorbid factors has to be considered before assessment as well as before commencing any repositioning treatment. Our aims were evaluation of the maneuvers efficacy and evaluation of the applicability of hybrid maneuver (HM) in patients with physical limitation. Study design and setting: This is a randomized study in 2 tertiary referral centers. Intervention: This is a therapeutic intervention. Patients: All consecutive patients with diagnosis of BPPV of posterior canal matching the inclusion criteria were enrolled. Patients underwent treatment soon after…

AdultMalemedicine.medical_specialtyBenign paroxysmal positional vertigoPostureNystagmusPatient Positioninglaw.inventionsymbols.namesakeRandomized controlled triallawElderly populationotorhinolaryngologic diseasesmedicineEffective treatmentHumansBenign Paroxysmal Positional VertigoFisher's exact testAgedRetrospective StudiesAged 80 and overPosterior Semicircular Canalbusiness.industryMiddle Agedmedicine.diseaseSemicircular CanalsSurgeryPhysical limitationsTreatment OutcomeOtorhinolaryngologysymbolsVertigoFemalemedicine.symptombusinessFollow-Up StudiesAmerican journal of otolaryngology
researchProduct

Switching to a Second Thiopurine in Adult and Elderly Patients With Inflammatory Bowel Disease: A Nationwide Study From the ENEIDA Registry

2020

Abstract Background and Aims Although commonly used in inflammatory bowel disease [IBD], thiopurines frequently cause intolerance, and switching to a second thiopurine has only been reported in some small series. Ours aims in this study were to evaluate the safety of switching to a second thiopurine in a large cohort, and to assess the impact of age on tolerance. Methods Adult IBD patients from the ENEIDA registry, who were switched to a second thiopurine due to adverse events [excluding malignancies and infections], were identified. At the beginning of thiopurine treatment, patients were divided by age into two groups: 18–50 and over 60 years of age. The rate and concordance of adverse eve…

AdultMalemedicine.medical_specialtyDrug-Related Side Effects and Adverse ReactionsConcordanceInflammatory bowel diseaseelderly03 medical and health sciences0302 clinical medicineinflammatory bowel diseaseInternal medicineAzathioprinemedicineHumans030212 general & internal medicinePractice Patterns Physicians'Adverse effectThiopurine elderly inflammatory bowel diseaseAgedThiopurine methyltransferasebiologyThiopurinebusiness.industryDrug SubstitutionMercaptopurineGastroenterologyAge FactorsGeneral MedicineOdds ratioDrug Tolerancemedicine.diseaseInflammatory Bowel DiseasesConfidence intervaldigestive system diseasesClinical PracticeSpainbiology.proteinAcute pancreatitis030211 gastroenterology & hepatologyFemaleRisk AdjustmentDrug MonitoringbusinessImmunosuppressive Agents
researchProduct

Kinematic analysis of motor strategies in frail aged adults during the Timed Up and Go: how to spot the motor frailty?

2015

Asma Hassani,1 Alexandre Kubicki,2,3 Vincent Brost,1 France Mourey,2,4 Fan Yang1 1Laboratoire LE2I CNRS 6306, Universit&amp;eacute; de Bourgogne, Dijon, France; 2Institut National de la Sant&amp;eacute; et de la Recherche M&amp;eacute;dicale (INSERM), Cognition Action et Plasticit&amp;eacute; Sensori-Motrice, Campus Universitaire, Universit&amp;eacute; de Bourgogne, Dijon, France; 3Centre Hospitalier Universitaire de Dijon, H&amp;ocirc;pital de Champmaillot, Dijon, France; 4Facult&amp;eacute; de M&amp;eacute;decine, Universit&amp;eacute; de Bourgogne, Dijon, France Objective: The purpose of this work was to analyze and compare the movement kinematics of sit-to-stand (STS) and back-to-sit (B…

AdultMalemedicine.medical_specialtyFrail ElderlyMovementKinematicsTimed Up and Go testTimed Up and Go testsarcopeniaYoung AdultPhysical medicine and rehabilitationElderly persons[ INFO.INFO-BI ] Computer Science [cs]/Bioinformatics [q-bio.QM]fallsmedicineHumansFrail elderlyalzheimers-diseaseOriginal ResearchriskAged 80 and overfrailty effectsWork (physics)agingAge FactorsGeneral Medicinedwelling older-adultsmobilityBiomechanical Phenomenakinematicselderly personsClinical Interventions in AgingPhysical therapyFemaleGeriatrics and Gerontology[INFO.INFO-BI]Computer Science [cs]/Bioinformatics [q-bio.QM]Psychologyhuman activitiesTimed up and go
researchProduct

Assessment of the interest of the geriatric oncology consultation among French general practitioners

2015

International audience; OBJECTIVE: We assessed the interest of the geriatric oncology (GO) consultation (GOC) among general practitioners (GPs). MATERIALS AND METHODS: We conducted a survey among GPs whose patients had had a GOC in 2012. A questionnaire was sent to GPs. The 1st part collected GPs' characteristics including medical education in geriatrics and GO, and knowledge of GOC. The following parts concerned the GOC and included the cancer type, GOC report and care plan. RESULTS: One-hundred twenty-six questionnaires corresponding to 94 GPs were collected. Concerning the GPs' characteristics, age range 50-59 (44.7%), men (62.8%) and urban practice (79.8%) were the most represented, 80.…

AdultMalemedicine.medical_specialtyGeriatric oncology consultationAttitude of Health Personnelphysicianseducation[SDV.CAN]Life Sciences [q-bio]/Cancer[ SDV.MHEP.GEG ] Life Sciences [q-bio]/Human health and pathology/Geriatry and gerontologyMedical Oncology[ SDV.CAN ] Life Sciences [q-bio]/Cancer03 medical and health sciences0302 clinical medicineresponse ratesNeoplasmsSurveys and QuestionnairesCare planGeneral practitionersmedicineHumans030212 general & internal medicinecareReferral and ConsultationGeriatricscancer-patientsbusiness.industry[SDV.MHEP.GEG]Life Sciences [q-bio]/Human health and pathology/Geriatry and gerontologyCancer typeMiddle Aged3. Good healthElderly patientsOncologyGeriatric oncologyGeriatrics030220 oncology & carcinogenesisFamily medicineGlobal Positioning SystemFemaleFranceGeriatrics and Gerontologybusinessmanagement
researchProduct